Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy

May 21, 2026 updated by: Ankit Bharat, Northwestern University

A Prospective Clinical Registry Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy

The primary goal of this study is to collect short-term and long-term health outcomes of a robotic transhiatal esophagectomy procedure. Clinical (or health) outcomes measure the effect of the procedure on your overall health status. During this procedure, the surgeon will remove all or part of your esophagus. We want to identify patients who will have this procedure. We will look at data elements before, during, and after your procedure to understand the impact of this surgery on your post-operative clinical outcomes.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Esophagectomy is a complex surgical procedure performed to treat various esophageal disorders. The surgery involves the removal of all or part of the esophagus and reconstruction using other parts of the gastrointestinal tract. Different surgical approaches and techniques have been developed, including open (transthoracic or transhiatal), minimally invasive (video-assisted thoracoscopic surgery or robotic-assisted), and hybrid approaches. These techniques may yield different clinical outcomes, and there is still ongoing debate regarding the optimal approach. Nevertheless, minimally invasive approaches, including robotic esophagectomy, are generally preferred given the lower morbidity. This prospective clinical registry aims to investigate outcomes of elective robotic transhiatal esophagectomy, the preferred approach at Northwestern Memorial Hospital, for adult patients undergoing this procedure. By collecting clinical and demographic data prospectively, we hope to identify factors that contribute to improved outcomes and guide future surgical practice.

Study Type

Observational

Enrollment (Estimated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Participants will be identified in the Thoracic Surgery clinic or in the inpatient setting based on the surgeon's expertise who need to undergo an elective esophagectomy procedure.

Description

Inclusion Criteria:

  • Adult patients (18 years or older)
  • Patients undergoing elective esophagectomy for any indication
  • Patients who have already had an elective esophagectomy for any indication
  • Patients with consent providing capacity

Exclusion Criteria:

  • Patients undergoing emergent esophagectomy
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Vulnerable Populations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with Anastomotic Leak
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Esophageal Stricture
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Pneumonia
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants Requiring Ventilation >48 Hours
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Empyema
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Pulmonary Embolism
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Deep Venous Thrombosis
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Gastric Outlet Obstruction
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Stroke
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Atrial Fibrillation
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Vocal Cord Paralysis
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Myocardial Infarction
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Chylothorax
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Acute Renal Injury
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Wound Infections
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Rates of Re-operation
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Rates of Re-Admission
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Number of Participants with Intensive Care Unit (ICU) Stay
Time Frame: During first 3 months postop
Postoperative Complication
During first 3 months postop
Rates of Length of Hospital Stay
Time Frame: Postoperative
Postoperative Complication
Postoperative
Rates of 30-day Survival
Time Frame: Postoperative
Postoperative Complication
Postoperative
Rates of 90-day Survival Rates
Time Frame: Postoperative
Postoperative Complication
Postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operative Time of Surgery
Time Frame: Intraoperative
Length of Surgery
Intraoperative
Rates of Blood Loss
Time Frame: Intraoperative
Did the Participant Lose Any Blood During the Surgery
Intraoperative
Number of Participants with Conversion Rates to Open Esophagectomy
Time Frame: Intraoperative
Intraoperative
Number of Participants with Lymph nodes in the Final Specimen
Time Frame: Intraoperative
Pathological Variables
Intraoperative
Number of Participants with Proximal and Distal Margins
Time Frame: Intraoperative
Pathological Variables
Intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ankit Bharat, MD, Northwestern University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 11, 2023

Primary Completion (Estimated)

May 25, 2028

Study Completion (Estimated)

May 25, 2028

Study Registration Dates

First Submitted

July 11, 2023

First Submitted That Met QC Criteria

July 11, 2023

First Posted (Actual)

July 18, 2023

Study Record Updates

Last Update Posted (Actual)

May 26, 2026

Last Update Submitted That Met QC Criteria

May 21, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STU00219267

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Esophagectomy

Clinical Trials on Esophagectomy

Subscribe